Emerituswa Revenue Growth Rates (ESC), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Emeritus Corpwa  (ESC)
 

ESC's Revenue Growth by Quarter and Year

Emerituswa's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ESC Revenue (in millions $) FY 2014 FY 2013 FY 2012 FY 2011
4th Quarter December -
3rd Quarter September -
2nd Quarter June -
1st Quarter March 521.83
FY 521.83





ESC Revenue first quarter 2014 Y/Y Growth Comment
Emeritus Corpwa reported Revenue increase of 10.47% year on year in the first quarter 2014, to $ 521.83 millions, this is lower than Emeritus Corpwa's recent average Revenue improvement of 24.37%.

Looking into first quarter 2014 results within Medical Equipment & Supplies industry 59 other companies have achieved higher Revenue growth. While Emeritus Corpwa' s Revenue growth of 10.47% ranks overall at the positon no. 1460 in the first quarter 2014.


ESC Revenue ( Y/Y Growth %) 2014
 2013 2012 2011
4th Quarter December - 18.98 % 16.26 % 32.63 %
3rd Quarter September - 29.02 % 1.83 % 49.73 %
2nd Quarter June - 26.98 % 3.05 % 52.09 %
1st Quarter March 10.47 % 46.25 % -9.86 % 52.99 %
FY   - 29.29 % 2.98 % -

Financial Statements
Emerituswa's first quarter 2014 Revenue $ 521.83 millions ESC's Income Statement
Emerituswa's first quarter 2013 Revenue $ 472.37 millions Quarterly ESC's Income Statement


ESC Revenue (Quarter on Quarter Growth %)

 2014
 2013 2012 2011
4th Quarter December - 5.87 % 14.81 % 0.56 %
3rd Quarter September - 3.32 % 1.69 % 2.91 %
2nd Quarter June - 0.75 % 16.04 % 1.5 %
1st Quarter March 0.24 % 7.96 % -14.19 % 26.27 %
FY (Year on Year)   - 29.29 % 2.98 % -


Back to ESC Growth rate Comparisons >> Back to ESC Growth rate Comparisons >>


Revenue first quarter 2014 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #60
Healthcare Sector #197
Overall #1460

Revenue Y/Y Growth Statistics
High Average Low
52.99 % 24.37 % -9.86 %
(Sep 30 2013)   (Dec 31 2013)
Revenue first quarter 2014 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #60
Healthcare Sector #197
Overall #1460
Revenue Y/Y Growth Statistics
High Average Low
52.99 % 24.37 % -9.86 %
(Sep 30 2013)   (Dec 31 2013)

Revenue by Quarter for the Fiscal Years 2011, 2012, 2013, 2014

Emerituswa's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
28.35 % 9.25 % 0.24 %
(Dec 31 2012)  


ESC's I. Quarter Q/Q Revenue Comment
Emeritus Corpwa achieved in the I. Quarter 2014 below company average Revenue growth of 0.24% quarter on quarter, to $ 521.83 millions.

Within Medical Equipment & Supplies industry 45 other companies have achieved higher Revenue quarter on quarter growth. While Emerituswa's Revenue growth quarter on quarter, overall rank is 1503.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #46
Healthcare Sector #165
Overall #1503
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #46
Healthcare Sector #165
Overall #1503
Revenue Q/Q Growth Statistics
High Average Low
28.35 % 9.25 % 0.24 %
(Dec 31 2012)  


ESC's I. Quarter Q/Q Revenue Comment
Emeritus Corpwa achieved in the I. Quarter 2014 below company average Revenue growth of 0.24% quarter on quarter, to $ 521.83 millions.

Within Medical Equipment & Supplies industry 45 other companies have achieved higher Revenue quarter on quarter growth. While Emerituswa's Revenue growth quarter on quarter, overall rank is 1503.


Emerituswa's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Mar 31 2014)		 12 Months Ending
(Dec 31 2013)		 12 Months Ending
(Sep 30 2013)		 12 Months Ending
(Jun 30 2013)		 12 Months Ending
(Mar 31 2013)
Cumulative Revenue 12 Months Ending $ 2,010.08 $ 1,960.62 $ 1,877.59 $ 1,766.98 $ 1,665.85
Y / Y Revenue Growth (TTM) 20.66 % 29.29 % 29.02 % 21.99 % 15.9 %
Year on Year Revenue Growth Overall Ranking # 505 # 530 # 530 # 530 # 0
Seqeuential Revenue Change (TTM) 2.52 % 4.42 % 6.26 % 6.07 % 9.85 %
Seq. Revenue Growth (TTM) Overall Ranking # 1019 # 1762 # 0 # 0 # 0


Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Mar 31 2014 period, Emerituswa's cumulative twelve months Revenue were $ 2,010 millions, company would post below average annual Revenue growth of 9.85% year on year, if the fiscal year would end at Mar 31 2014.
A slow-down in the Emerituswa's Revenue growth from the 520.59% growth in Dec 31 2013.

In the Healthcare sector 67 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 505, from total ranking in previous quarter at 530.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 38
Healthcare Sector # 68
Overall # 505

Revenue TTM Y/Y Growth Statistics
High Average Low
28.19 %
 28.19 %
28.19 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 38
Sector # 122
S&P 500 # 1019
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Mar 31 2014 period, Emerituswa's cumulative twelve months Revenue were $ 2,010 millions, company would post below average annual Revenue growth of 28.19% year on year, if the fiscal year would end at Mar 31 2014.
A slow-down in the Emerituswa's Revenue growth from the 520.59% growth in Dec 31 2013.

In the Healthcare sector 67 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 505, from total ranking in previous quarter at 530.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 38
Healthcare Sector # 68
Overall # 505

Revenue TTM Y/Y Growth Statistics
High Average Low
28.19 %
28.19 %
28.19 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 38
Sector # 122
S&P 500 # 1019




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
ESC's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue growth for the quarter ending Mar 31 2014 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2014
Celgene Corp18.12%$ 18.121 millions
United Therapeutics Corporation18.06%$ 18.058 millions
Bio techne Corp17.98%$ 17.981 millions
Align Technology inc 17.62%$ 17.623 millions
Magellan Health inc 17.61%$ 17.610 millions
Vyant Bio Inc 17.37%$ 17.372 millions
Infusystem Holdings Inc17.28%$ 17.285 millions
Dyax Corp17.25%$ 17.251 millions
Myriad Genetics Inc 16.91%$ 16.905 millions
Invo Fertility Inc 16.87%$ 16.867 millions
Amag Pharmaceuticals inc 16.53%$ 16.527 millions
Escalon Medical Corp 15.67%$ 15.668 millions
Iridex Corp15.55%$ 15.550 millions
Abiomed Inc 15.48%$ 15.476 millions
Antares Pharma Inc 14.88%$ 14.884 millions
Merit Medical Systems Inc14.71%$ 14.707 millions
Inotiv Inc 14.66%$ 14.663 millions
Heartbeam Inc 14.63%$ 14.634 millions
Baxter International Inc 14.59%$ 14.588 millions
Bohai Pharmaceuticals Group, Inc.14.19%$ 14.188 millions
Healthcare Services Group Inc 13.97%$ 13.969 millions
Apyx Medical Corp13.80%$ 13.799 millions
Medicines Co13.79%$ 13.792 millions
Addus Homecare Corp13.79%$ 13.786 millions
Vanda Pharmaceuticals Inc 13.32%$ 13.324 millions
Ipc Healthcare, Inc.12.83%$ 12.826 millions
Allergan plc12.78%$ 12.777 millions
Immucell Corporation12.73%$ 12.726 millions
Star Equity Holdings Inc 12.57%$ 12.567 millions
Acorda Therapeutics Inc 12.04%$ 12.041 millions


About Emerituswa Revenue Growth Rates (ESC), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: the company’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.